These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 492215)

  • 1. The importance of serum pyruvate kinase in neuromuscular diseases and carrier states.
    Sage J; Inati Y; Samaha F
    Muscle Nerve; 1979; 2(5):390-3. PubMed ID: 492215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D; Colletto GM; Zatz M
    Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum pyruvate kinase (PK) in the diagnosis of neuromuscular diseases].
    Chen Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):338-41. PubMed ID: 3836824
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
    Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
    Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
    Ionasescu V; Burmeister L; Hanson J
    Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate kinase: diagnostic value in neuromuscular disease.
    Weinstock IM; Behrendt J; Wittshire HE; Keleman J; Louis S
    Clin Chim Acta; 1977 Nov; 80(3):415-22. PubMed ID: 912912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pyruvate kinase in carriers of Duchenne muscular dystrophy.
    Hardy MF; Gardner-Medwin D; Pennington RJ
    J Neurol Sci; 1977 May; 32(1):137-9. PubMed ID: 864489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.